Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Disc Medicine, Inc. - Common Stock
(NQ:
IRON
)
73.54
-6.18 (-7.75%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Disc Medicine, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 12, 2023
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
↗
June 12, 2023
Via
Benzinga
Expert Ratings for Disc Medicine
↗
June 07, 2023
Via
Benzinga
Why Shares of Disc Medicine Opco Climbed This Week
↗
June 01, 2023
The company's shares rose after analysts maintained their buy ratings for the stock.
Via
The Motley Fool
Crude Oil Down Over 1%; Planet Labs PBC Shares Tumble
↗
June 09, 2023
U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 50 points on Friday. The Dow traded up 0.14% to 33,882.18 while the NASDAQ rose 0.35% to 13,284.55. The S&P 500, also...
Via
Benzinga
Why Are Disc Medicine Shares Trading Higher Today
↗
June 09, 2023
Disc Medicine Inc (NASDAQ: IRON) presented preliminary findings from its ongoing Phase 2 BEACON trial of bitopertin for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) at the...
Via
Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 09, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827.
Via
Benzinga
Expert Ratings for Disc Medicine
↗
April 26, 2023
Via
Benzinga
Dow Edges Lower; Sientra Shares Spike Higher
↗
June 09, 2023
U.S. stocks traded pared some gains midway through trading, with Dow Jones turning lower on Friday. The Dow traded down 0.07% to 33,810.44 while the NASDAQ rose 0.17% to 13,260.91. The S&P 500, also...
Via
Benzinga
Why Perfectly Rated Disc Medicine, With A 275% Move This Year, Just Put Up Another Big Gain
↗
June 09, 2023
The company is testing a treatment for patients with a disease that causes sunlight intolerance.
Via
Investor's Business Daily
Tesla, Adobe, Mission Produce And Other Big Stocks Moving Higher On Friday
↗
June 09, 2023
U.S. stocks traded higher, with the Dow Jones rising around 100 points on Friday. Here are some big stocks recording gains in today’s session. Braze, Inc. (NASDAQ: BRZE) shares climbed 20.4% to $ 40.82...
Via
Benzinga
Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
June 09, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
↗
June 07, 2023
Via
Benzinga
Disc Medicine to Participate in the Jefferies Healthcare Conference
May 31, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023
↗
May 17, 2023
Via
Benzinga
Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
May 11, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023
↗
April 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
↗
April 21, 2023
Via
Benzinga
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
April 21, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
↗
April 20, 2023
Via
Benzinga
Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP)
April 13, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
March 31, 2023
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Via
Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
↗
March 31, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update
March 31, 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
March 24, 2023
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
↗
March 23, 2023
Via
Benzinga
Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA)
March 21, 2023
IND accepted for phase 2 clinical trial in DBA patients; study is expected to initiate mid-year 2023
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Opco Inc (NASDAQ: IRON) Investor Notice: Investigation over Possible Securities Laws Violations
↗
March 20, 2023
San Diego, CA -- (SBWIRE) -- 03/20/2023 -- An investigation was announced for investors of Disc Medicine Opco Inc (NASDAQ: IRON) shares over potential securities laws violations in connection with...
Via
SBWire
Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement
↗
March 18, 2023
Livzon Pharmaceutical Group entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease therapy from Onconic Therapeutics. Meanwhile, Gracell Biotech announced that it had...
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
